Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells

Journal of Hypertension

Volumn 34, Issue 2, 2016, Pages 253-265

  Aguado, Andrea ^a   Fischer, Thierry ^b   Rodríguez, Cristina ^c   Manea, Adrian ^d   Martínez González, José ^c   Touyz, Rhian M ^e   Hernanz, Raquel ^f   Alonso, M Jesús ^f   Dixon, Dan A ^g   Briones, Ana M ^a   Salaices, Mercedes ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c Institut Català de Ciències Cardiovasculars   (Spain)

^d INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSIDAD REY JUAN CARLOS   (Spain)

^g UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Cell migration; Hu antigen R; Interleukin 1 ; NADPH oxidase; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; ELAV LIKE PROTEIN 1; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; NOX1 PROTEIN, HUMAN; NOX4 PROTEIN, HUMAN; NOX4 PROTEIN, RAT; OXIDOREDUCTASE;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RNA STABILITY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; ELAV-LIKE PROTEIN 1; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-1BETA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; RATS; REACTIVE OXYGEN SPECIES; RNA STABILITY; RNA, MESSENGER;

EID: 84957428631     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000801     Document Type: Article

References (52)

1. Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011; 10:453-471.
2. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 2008; 29:367-374.
3. Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 2010; 12:135-142.
4. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 2008; 45:1340-1351.
5. Katsuyama M, Miller FJ Jr. An oxidized extracellular oxidationreduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arterioscler Thromb Vasc Biol 2010; 30:2234-2241.
6. Al Ghouleh I, Rodríguez A, Pagano PJ, Csányi G. Proteomic analysis identifies an NADPH oxidase 1 (Nox1)-mediated role for actin-related protein 2/3 complex subunit 2 (ARPC2) in promoting smooth muscle cell migration. Int J Mol Sci 2013; 14:20220-20235.
7. Chen F, Haigh S, Barman S, Fulton DJ. From form to function: The role of Nox4 in the cardiovascular system. Front Physiol 2012; 3:412.
8. Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001; 88:888-894.
9. Manea A, Tanase LI, Raicu M, Simionescu M. JAK/STAT signaling pathway regulates Nox1 and Nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2010; 30:105-112.
10. Briones AM, Tabet F, Callera GE, Montezano AC, Yogi A, He Y, et al. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J Am Soc Hypertens 2011; 5:137-153.
11. Pérez-Girón JV, Palacios R, Martín A, Hernanz R, Aguado A, Martínez-Revelles S, et al. Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2014; 306:H1582-1593.
12. Katsuyama M, Fan C, Arakawa N, Nishinaka T, Miyagishi M, Taira K, Yabe-Nishimura C. Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem J 2005; 386(Pt 2):255-261.
13. Cevik MO, Katsuyama M, Kanda S, Kaneko T, Iwata K, Ibi M, et al. The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: possible involvement of the ERK1/2-JunB pathway. Biochem Biophys Res Commun 2008; 374:351-355.
14. Meisner NC, Filipowicz W. Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression. Adv Exp Med Biol 2011; 700:106-123.
15. Diebold I, Petry A, Hess J, Görlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell 2010; 21:2087-2096.
16. Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, et al. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006; 290:L661-L673.
17. Manea A, Tanase LI, Raicu M, Simionescu M. Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophys Res Commun 2010; 396:901-907.
18. Ellmark SH, Dusting GJ, Fui MN, Guzzo-Pernell N, Drummond GR. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res 2005; 65:495-504.
19. Aguado A, Galán M, Zhenyukh O, Wiggers GA, Roque FR, Redondo S, et al. Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways. Toxicol Appl Pharmacol 2013; 268:188-200.
20. Orriols M, Guadall A, Galán M, Martí-Pàmies I, Varona S, Rodríguez-Calvo R, et al. Lysyl Oxidase (LOX) in vascular remodelling: insight from a new animal model. Thromb Haemost 2014; 112:812-824.
21. Aotani Y, Saitoh Y. Structure determination of MS-444; a new myosin light chain kinase inhibitor. J Antibiot 1995; 48:952-953.
22. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 2004; 23:3092-3102.
23. Meisner NC, Hintersteiner M, Mueller K, Bauer R, Seifert JM, Naegeli HU, et al. Identification and mechanistic characterization of lowmolecular-weight inhibitors for HuR. Nat Chem Biol 2007; 3:508-515.
24. Xu S, Touyz RM. Reactive oxygen species and vascular remodelling in hypertension: still alive. Can J Cardiol 2006; 22:947-951.
25. Lassègue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010; 30:653-661.
26. Vicenová B, Vopálenský V, Burýsek L, Pospísek M. Emerging role of interleukin-1 in cardiovascular diseases. Physiol Res 2009; 58:481-498.
27. Martín A, Pérez-Girón JV, Hernanz R, Palacios R, Briones AM, Fortunõ A, et al. Peroxisome proliferator-activated receptor-g activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. J Hypertens 2012; 30:315-326.
28. Abdelmohsen K, Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA 2010; 1:214-229.
29. Yang X, Wang W, Fan J, Lal A, Yang D, Cheng H, Gorospe M. Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR. J Biol Chem 2004; 279:49298-49306.
30. Woodhoo A, Iruarrizaga-Lejarreta M, Beraza N, García-Rodríguez JL, Embade N, Fernández-Ramos D, et al. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis. Hepatology 2012; 56:1870-1882.
31. Aguado A, Rodríguez C, Martínez-Revelles S, Avendanõ MS, Zhenyukh O, Orriols M, et al. HuR mediates the synergistic effects of angiotensin II and IL-1b on vascular COX-2 expression and cell migration. Br J Pharmacol 2015; 172:3028-3042.
32. Altenhöfer S, Radermacher KA, Kleikers PW, Wingler K, Schmidt HH. Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal 2015; 23:406-427.
33. Gray SP, Di Marco E, Okabe J, Szyndralewiez C, Heitz F, Montezano AC, et al. NADPH oxidase 1 plays a key role in diabetes mellitusaccelerated atherosclerosis. Circulation 2013; 127:1888-1902.
34. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, et al. Nox1 is involved in angiotensin II-mediated hypertension: A study in Nox1-deficient mice. Circulation 2005; 112:2677-2685.
35. Katsuyama M, Matsuno K, Yabe-Nishimura C. Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme. J Clin Biochem Nutr 2012; 50:9-22.
36. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factorbeta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005; 97:900-907.
37. Richard D, Wolf C, Barbe U, Kefi K, Bausero P, Visioli F. Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway. Biochem Biophys Res Commun 2009; 38:516-522.
38. Paneni F, Osto E, Costantino S, Mateescu B, Briand S, Coppolino G, et al. Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction. Circulation 2013; 127:1229-1240.
39. Takac I, Schröder K, Zhang L, Lardy B, Anilkumar N, Lambeth JD, et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem 2011; 286:13304-13313.
40. Velarde V, de la Cerda PM, Duarte C, Arancibia F, Abbott E, González A, et al. Role of reactive oxygen species in bradykinin-induced proliferation of vascular smooth muscle cells. Biol Res 2004; 37:419-430.
41. Yoo SK, Starnes TW, Deng Q, Huttenlocher A. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 2011; 480:109-112.
42. Schröder K. NADPH oxidases in redox regulation of cell adhesion and migration. Antioxid Redox Signal 2014; 20:2043-2058.
43. Stanley A, Thompson K, Hynes A, Brakebusch C, Quondamatteo F. NADPH oxidase complex-derived reactive oxygen species, the actin cytoskeleton, and Rho GTPases in cell migration. Antioxid Redox Signal 2014; 20:2026-2042.
44. Martínez-Revelles S, Avendanõ MS, García-Redondo AB, Alvarez Y, Aguado A, Pérez-Girón JV, et al. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid Redox Signal 2013; 18:51-65.
45. Pullmann R Jr, Juhaszova M, López de Silanes I, Kawai T, Mazan-Mamczarz K, Halushka MK, et al. Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR. J Biol Chem 2005; 280:22819-22826.
46. Clempus RE, Sorescu D, Dikalova AE, Pounkova L, Jo P, Sorescu GP, et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2007; 27:42-48.
47. Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 2007; 45(Suppl A):A25-A32.
48. Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, et al. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2009; 29:480-487.
49. Touyz RM, Montezano AC. Vascular Nox4: A multifarious NADPH oxidase. Circ Res 2012; 110:1159-1161.
50. Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, et al. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 2012; 110:1217-1225.
51. Lassègue B, San Martín A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 2012; 110:1364-1390.
52. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24:677-683.